410 related articles for article (PubMed ID: 31919501)
1. Treatment of Perianal Fistulas in Crohn's Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial.
Wasmann KA; de Groof EJ; Stellingwerf ME; D'Haens GR; Ponsioen CY; Gecse KB; Dijkgraaf MGW; Gerhards MF; Jansen JM; Pronk A; van Tuyl SAC; Zimmerman DDE; Bruin KF; Spinelli A; Danese S; van der Bilt JDW; Mundt MW; Bemelman WA; Buskens CJ
J Crohns Colitis; 2020 Sep; 14(8):1049-1056. PubMed ID: 31919501
[TBL] [Abstract][Full Text] [Related]
2. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy in the treatment of perianal fistulas in Crohn's disease (PISA-II): a patient preference randomised trial.
Meima-van Praag EM; van Rijn KL; Wasmann KATGM; Snijder HJ; Stoker J; D'Haens GR; Gecse KB; Gerhards MF; Jansen JM; Dijkgraaf MGW; van der Bilt JDW; Mundt MW; Spinelli A; Danese S; Bemelman WA; Buskens CJ
Lancet Gastroenterol Hepatol; 2022 Jul; 7(7):617-626. PubMed ID: 35427495
[TBL] [Abstract][Full Text] [Related]
3. Multimodal treatment of perianal fistulas in Crohn's disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial.
de Groof EJ; Buskens CJ; Ponsioen CY; Dijkgraaf MG; D'Haens GR; Srivastava N; van Acker GJ; Jansen JM; Gerhards MF; Dijkstra G; Lange JF; Witteman BJ; Kruyt PM; Pronk A; van Tuyl SA; Bodelier A; Crolla RM; West RL; Vrijland WW; Consten EC; Brink MA; Tuynman JB; de Boer NK; Breukink SO; Pierik MJ; Oldenburg B; van der Meulen AE; Bonsing BA; Spinelli A; Danese S; Sacchi M; Warusavitarne J; Hart A; Yassin NA; Kennelly RP; Cullen GJ; Winter DC; Hawthorne AB; Torkington J; Bemelman WA
Trials; 2015 Aug; 16():366. PubMed ID: 26289163
[TBL] [Abstract][Full Text] [Related]
4. Treatment of perianal fistula in Crohn's disease: a systematic review and meta-analysis comparing seton drainage and anti-tumour necrosis factor treatment.
de Groof EJ; Sahami S; Lucas C; Ponsioen CY; Bemelman WA; Buskens CJ
Colorectal Dis; 2016 Jul; 18(7):667-75. PubMed ID: 26921847
[TBL] [Abstract][Full Text] [Related]
5. Treatment of complex perianal fistulas with seton and infliximab in adolescents with Crohn's disease.
Hukkinen M; Pakarinen MP; Piekkala M; Koivusalo A; Rintala R; Kolho KL
J Crohns Colitis; 2014 Aug; 8(8):756-62. PubMed ID: 24447625
[TBL] [Abstract][Full Text] [Related]
6. Short-term anti-TNF therapy with surgical closure versus anti-TNF therapy alone for Crohn's perianal fistulas (PISA-II): long-term outcomes of an international, multicentre patient preference, randomised controlled trial.
Meima-van Praag EM; Becker MAJ; van Rijn KL; Wasmann KATGM; Stoker J; D'Haens GRAM; Ponsioen CY; Gecse KB; Dijkgraaf MGW; Spinelli A; Danese S; Bemelman WA; Buskens CJ
EClinicalMedicine; 2023 Jul; 61():102045. PubMed ID: 37457118
[TBL] [Abstract][Full Text] [Related]
7. Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
Topstad DR; Panaccione R; Heine JA; Johnson DR; MacLean AR; Buie WD
Dis Colon Rectum; 2003 May; 46(5):577-83. PubMed ID: 12792431
[TBL] [Abstract][Full Text] [Related]
8. Use of endoscopic ultrasound to guide combination medical and surgical therapy for patients with Crohn's perianal fistulas.
Schwartz DA; White CM; Wise PE; Herline AJ
Inflamm Bowel Dis; 2005 Aug; 11(8):727-32. PubMed ID: 16043987
[TBL] [Abstract][Full Text] [Related]
9. Surgical closure, mainly with glue injection and anti-tumour necrosis factor α, in fistulizing perianal Crohn's disease: A multicentre randomized controlled trial.
Abramowitz L; Brochard C; Pigot F; Roumeguere P; Pillant H; Vinson Bonnet B; Faucheron JL; Senéjoux A; Bonnaud G; Meurette G; Fayette JM; Train C; Staumont G; Siproudhis L; Bouchard D
Colorectal Dis; 2022 Feb; 24(2):210-219. PubMed ID: 34623746
[TBL] [Abstract][Full Text] [Related]
10. Higher anti-tumor necrosis factor levels are associated with perianal fistula healing and fistula closure in Crohn's disease.
Plevris N; Jenkinson PW; Arnott ID; Jones GR; Lees CW
Eur J Gastroenterol Hepatol; 2020 Jan; 32(1):32-37. PubMed ID: 31567638
[TBL] [Abstract][Full Text] [Related]
11. The results of seton drainage combined with anti-TNFα therapy for anal fistula in Crohn's disease.
Haennig A; Staumont G; Lepage B; Faure P; Alric L; Buscail L; Bournet B; Moreau J
Colorectal Dis; 2015 Apr; 17(4):311-9. PubMed ID: 25425534
[TBL] [Abstract][Full Text] [Related]
12. Comparative perianal fistula closure rates following autologous adipose tissue-derived stem cell transplantation or treatment with anti-tumor necrosis factor agents after seton placement in patients with Crohn's disease: a retrospective observational study.
Park MY; Yoon YS; Lee JL; Park SH; Ye BD; Yang SK; Yu CS
Stem Cell Res Ther; 2021 Jul; 12(1):401. PubMed ID: 34256838
[TBL] [Abstract][Full Text] [Related]
13. Anoperineal lesions in Crohn's disease: French recommendations for clinical practice.
Bouchard D; Abramowitz L; Bouguen G; Brochard C; Dabadie A; de Parades V; Eléouet-Kaplan M; Fathallah N; Faucheron JL; Maggiori L; Panis Y; Pigot F; Rouméguère P; Sénéjoux A; Siproudhis L; Staumont G; Suduca JM; Vinson-Bonnet B; Zeitoun JD
Tech Coloproctol; 2017 Sep; 21(9):683-691. PubMed ID: 28929282
[TBL] [Abstract][Full Text] [Related]
14. Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed?
Tanaka S; Matsuo K; Sasaki T; Nakano M; Sakai K; Beppu R; Yamashita Y; Maeda K; Aoyagi K
Hepatogastroenterology; 2010; 57(97):3-7. PubMed ID: 20422862
[TBL] [Abstract][Full Text] [Related]
15. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement.
Regueiro M; Mardini H
Inflamm Bowel Dis; 2003 Mar; 9(2):98-103. PubMed ID: 12769443
[TBL] [Abstract][Full Text] [Related]
16. Higher anti-TNF serum levels are associated with perianal fistula closure in Crohn's disease patients.
Strik AS; Löwenberg M; Buskens CJ; B Gecse K; I Ponsioen C; Bemelman WA; D'Haens GR
Scand J Gastroenterol; 2019 Apr; 54(4):453-458. PubMed ID: 31032686
[No Abstract] [Full Text] [Related]
17. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab.
Bouguen G; Siproudhis L; Gizard E; Wallenhorst T; Billioud V; Bretagne JF; Bigard MA; Peyrin-Biroulet L
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):975-81.e1-4. PubMed ID: 23376316
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of tumor necrosis factor-alpha inhibitors in fistulising perianal Crohn's disease].
Bor R; Farkas K; Bálint A; Szűcs M; Abrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Orv Hetil; 2013 Dec; 154(49):1943-8. PubMed ID: 24292112
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of combined anti-TNF-alpha and surgical therapy in perianal and enterocutaneous fistulizing Crohn's disease--clinical observations from a tertiary Eastern European center.
Bor R; Farkas K; Bálint A; Szucs M; Ábrahám S; Baradnay G; Wittmann T; Szepes Z; Nagy F; Molnár T
Scand J Gastroenterol; 2015 Feb; 50(2):182-7. PubMed ID: 25384713
[TBL] [Abstract][Full Text] [Related]
20. A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas.
Spradlin NM; Wise PE; Herline AJ; Muldoon RL; Rosen M; Schwartz DA
Am J Gastroenterol; 2008 Oct; 103(10):2527-35. PubMed ID: 18684178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
